Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia

Roche files next-generation Rituxan in USA, EU

Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.May 16, 2013

read all at

http://newdrugapprovals.wordpress.com/2013/05/17/roche-files-next-generation-rituxan-in-usa-eu/

zp8497586rq
Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter

By DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO Ph.D,( ICT), Worlddrugtracker, Helping millions with chemistry sites, million hits on google